Libra Tx Logo FINAL.png
  • Home

  • News

  • Careers

  • Contact

  • More

    Use tab to navigate through the menu items.
    • All Posts
    • Press Releases
    Search
    • Oct 19, 2021

    Libra Therapeutics Appoints Philip Lambert, Ph.D., as Chief Scientific Officer

    SAN DIEGO -- Libra Therapeutics, Inc. today announced the appointment of Philip Lambert, Ph.D., as the company’s first CSO. With more...
    • Sep 23, 2020

    Libra Launches with $29M Series A to Develop Novel Therapeutics for Neurodegenerative Diseases

    Libra launched with $29M to develop novel drug candidates focused on restoring the cellular balance lost in neurodegenerative diseases.
    Libra Tx Logo (White) FINAL.png

    info@libratherapeutics.com

    • Twitter
    • LinkedIn
    SEND US A MESSAGE

    Thanks for your message!

    © 2020 Libra Therapeutics, Inc. All rights reserved. 

    Privacy Policy  |  Terms of Use